Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.drudis.2020.08.001 http://scihub22266oqcxt.onion/10.1016/j.drudis.2020.08.001 32777537!7413203!32777537     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32777537&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Drug+Discov+Today 2020 ; 25 (10): 1801-1806 Nephropedia Template TP {{tp|p=32777537|t=2020. Global clinical trial mobilization for COVID-19: higher, faster, stronger |pdf=|usr=}}{{32777537}} gab.com Text Global clinical trial mobilization for COVID-19: higher, faster, stronger JO: Drug Discov Today http://www.kidney.de/pget.php?&tw=1&pmid=32777537 #FOAvip The clinical trial landscape for Coronavirus 2019 (COVID-19) is radically different from that of previous epidemics. Compared with H1N1, Ebola, and Zika, COVID-19 had an order of magnitude more clinical trials within the first 3 months following the declaration of a Public Health Emergency of International Concern (PHEIC). These trials have started much faster, are more geographically diverse, and are less likely to be funded by industry. However, the almost simultaneous design and initiation of hundreds of trials with 0.3 million participants across 78 countries creates the potential for congestion and inefficiencies and enhances risks for investors. Thus, an international coordination mechanism for clinical trials could be valuable in this and other situations. Twit Text FOAVip Global clinical trial mobilization for COVID-19: higher, faster, stronger ????Drug Discov Today http://www.kidney.de/pget.php?&tw=1&pmid=32777537 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32777537 #FOAvip English Wikipedia <ref>{{Cite pmid|32777537}}</ref> Global clinical trial mobilization for COVID-19: higher, faster, stronger #MMPMID32777537 Beall RF; Hollis A Drug Discov Today 2020[Oct]; 25 (10): 1801-1806 PMID32777537show ga The clinical trial landscape for Coronavirus 2019 (COVID-19) is radically different from that of previous epidemics. Compared with H1N1, Ebola, and Zika, COVID-19 had an order of magnitude more clinical trials within the first 3 months following the declaration of a Public Health Emergency of International Concern (PHEIC). These trials have started much faster, are more geographically diverse, and are less likely to be funded by industry. However, the almost simultaneous design and initiation of hundreds of trials with 0.3 million participants across 78 countries creates the potential for congestion and inefficiencies and enhances risks for investors. Thus, an international coordination mechanism for clinical trials could be valuable in this and other situations. |*Clinical Trials as Topic[MESH] |*International Cooperation[MESH] |*Multicenter Studies as Topic[MESH] |*Research Design[MESH] |COVID-19/diagnosis/epidemiology/*therapy/virology[MESH] |Cooperative Behavior[MESH] |Evidence-Based Medicine[MESH] |Host-Pathogen Interactions[MESH] |Humans[MESH] |SARS-CoV-2/*pathogenicity[MESH] |Time Factors[MESH]Global clinical trial mobilization for COVID-19: higher, faster, stron(epmc).pdf DeepDyve Pubget Overpricing